Who is sponsoring NCT06627062?

NCT06627062 is sponsored by Eye & ENT Hospital of Fudan University.

What drugs are being tested in NCT06627062?

Interventions in NCT06627062: moderate and severe subluxated lens extraction.

What condition does NCT06627062 study?

NCT06627062 studies Lens Subluxation.

Is NCT06627062 still recruiting?

NCT06627062 is currently completed. Last updated 4 October 2024.

Last reviewed 2024-10-04 · How we verify

NCT06627062

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Modified-simple Technique for Managing Moderate and Severe Subluxated Lens Extraction

Completed Last updated 4 October 2024

What this trial tests

trial testing moderate and severe subluxated lens extraction in Lens Subluxation in 9 participants. Completed in 28 February 2024.

Timeline

1 January 2023

Primary endpoint
1 June 2023

28 February 2024

Quick facts

Lead sponsor	Eye & ENT Hospital of Fudan University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	9
Start date	1 January 2023
Primary completion	1 June 2023
Estimated completion	28 February 2024
Sites	1 location across China

Drugs / interventions tested

moderate and severe subluxated lens extraction

Conditions studied

Lens Subluxation — all drugs for Lens Subluxation →

Sponsor

Eye & ENT Hospital of Fudan University

Who can join

Eligibility, any sex, with Lens Subluxation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators describe a modified knotless Z-suture technique to stabilize the capsular bag to the sclera in eyes with moderate and severe ectopic lentis requiring cataract surgery using a standard CTR. This technology has the advantages of few complications, low technical difficulty, and no dependence on complex equipment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intrascleral fixation of standard capsular tension ring: a modified-simple technique for managing moderate and severe subluxated lens extraction.
Ning L, Hong Y, Ji Y. · · 2026 · PMID 41613822 · DOI 10.1177/25158414251407874

Verify or expand the search:

Other Eye & ENT Hospital of Fudan University trials

Trials by the same sponsor.

NCT07522879 — A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Re · Phase 2 · not yet recruiting
NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
NCT07575334 — Acupuncture Therapy for Sudden Sensorineural Hearing Loss · NA · recruiting
NCT07320508 — Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · Phase 2 · recruiting
NCT07315802 — New Pattern of Retinal Laser Treatment for PDR · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06627062 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eye & ENT Hospital of Fudan University
Last refreshed: 4 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06627062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing